Volume 19, Issue 4 pp. 317-322

Impact of Reperfusion after 3 Hours of Symptom Onset on Tissue Fate in Acute Cerebral Ischemia

Oh Young Bang MD, PhD

Oh Young Bang MD, PhD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
David S. Liebeskind MD

David S. Liebeskind MD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
Brian H. Buck MD

Brian H. Buck MD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
Sa Rah Yoon MD

Sa Rah Yoon MD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
Jeffry R. Alger PhD

Jeffry R. Alger PhD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
Bruce Ovbiagele MD

Bruce Ovbiagele MD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
Jeffrey L. Saver MD

Jeffrey L. Saver MD

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
for the UCLA MRI Investigators

for the UCLA MRI Investigators

From the Department of Neurology, University of California, Los Angeles, CA (OYB, DSL, JRA, BO, JLS); Department of Neurology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea (OYB); Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada (BHB); Department of Radiology, University of California, Los Angeles, CA (SRY).
[Correction added after online publication 14-September-2009: Received date has been corrected.]

Search for more papers by this author
First published: 24 September 2009
Citations: 4
Correspondence: Address correspondence to Jeffrey L. Saver, MD, UCLA Stroke Center, 710 Westwood Plaza, Los Angeles, CA 90095. E-mail: [email protected].

Abstract

ABSTRACT

BACKGROUND

Reperfusion of penumbral tissue is a promising strategy for treatment of acute cerebral ischemia more than 3 hours from symptom onset. However, there has been only sparse direct evidence that reperfusion after 3 hours prevents infarct growth.

METHODS

We analyzed clinical and serial magnetic resonance imaging (MRI) data on patients who received endovascular recanalization therapy 3-12 hours after last known well time. Multimodal MRIs were acquired pretreatment, early (1-20 hours), and late (2-7 days) after treatment. Degree of recanalization was assessed on end of procedure catheter angiogram, degree of reperfusion on early posttreatment perfusion MRI, and infarct growth by analysis of diffusion lesion volumes on pretreatment and late MRIs.

RESULTS

Twenty-seven (12 men, 15 women) underwent endovascular recanalization procedures at 6.0 ± 2.1 hours (range, 3.0-11.5 hours) after last known well time. Immediate posttreatment perfusion lesion (Tmax ≥4 seconds) volume correlated strongly with infarct growth (r= .951, P < .001), exceeding the correlations of vessel recanalization score (r=−.198, P= .446) and pretreatment diffusion-perfusion mismatch volume (r= .518, P= .033). Without reperfusion, enlargement of DWI lesion volume was observed in all patients, and extent of enlargement depended on volume of immediate posttreatment perfusion defects.

CONCLUSION

Our data indicate that posttreatment reperfusion is the major determinant of threatened tissue outcome, and suggest reperfusion even after 3 hours of symptom onset can alter tissue fate over a wide range of mismatch volumes.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.